DOCUSATE SODIUM description, usages, side effects, indications, overdosage, supplying and lots more!

DOCUSATE SODIUM

Gemini Pharmaceuticals, Inc. dba ONDRA Pharmaceuticals

  • Description
  • Clinical Pharmacology
  • Indications & Usage
  • Contraindications
  • Warnings
  • Precautions
  • Side Effects
  • Overdosage
  • Dosage & Administration
  • How Supplied
  • Patient Counseling Information
  • Supplemental Patient Material
  • Boxed Warning
  • Patient Package Insert
Drug Facts

FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Active ingredient (in each tablet)

Docusate Sodium 100 mg

Purpose

Stool Softener

Uses

  • for relief of occasional constipation (irregularity).This product generally produces a bowel movement within 12 to 72 hours.

Warnings


Do not use

  • laxative products for longer than one week unless directed to do so by a doctor
  • if you are presently taking mineral oil unless told to do so by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed  a sudden change in bowel habits that lasts over 2 weeks

Stop use and ask a doctor if

  • you have rectal bleeding
  • you fail to have a bowel movement after use

If pregnant or breast-feeding,

ask a doctor before use

Keep out of Reach of Children.

Directions

Adults and children 12 years of age and older:
Children under 12 years of age:

Other information

  • Each tablet contains: Calcium 40 mg
  • Each tablet contains: Sodium 10  mg
  • Store at room temperature
  • Do not use if imprinted safety seal is broken or missing

Inactive ingredients

Croscarmellose Sodium, Dicalcium Phosphate, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Polyethylene Glycol, Pregelatinized Starch, Silica, Sodium Benzoate, Stearic Acid.

Questions?

If you have any questions or comments, or to report an adverse event, please contact 1 800-medline.

Principal Display Panel













Principal Display Panel

DOCUSATE SODIUM

DOCUSATE SODIUM TABLET, FILM COATED

Product Information

Product Type Human otc drug label Item Code (Source) NDC:51645-606
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
DOCUSATE SODIUM DOCUSATE 100 mg

Inactive Ingredients

Ingredient Name Strength
CROSCARMELLOSE SODIUM
ANHYDROUS DIBASIC CALCIUM PHOSPHATE
HYPROMELLOSES
MAGNESIUM STEARATE
cellulose, microcrystalline
polyethylene glycol
STARCH, CORN
SILICON DIOXIDE
SODIUM BENZOATE
STEARIC ACID

Product Characteristics

Color Size Imprint Code Shape
white 11 mm GPI;S1 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:51645-606-01 100 in 1 BOTTLE, PLASTIC

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part334 2012-03-30


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.